abstract |
The present invention relates to multimer fusion proteins that bind to human Fc receptors. The invention also relates to therapeutic compositions comprising said proteins and their use in the treatment of immune disorders. The fusion protein comprises a tailpiece in the absence of a cysteine residue at position 309. |